Clinical features and outcomes of bowel perforation in primary pediatric gastrointestinal lymphoma

Abstract Background Whether surgery can improve the prognosis of patients with primary pediatric gastrointestinal lymphoma (PPGL) who experienced bowel perforation remains controversial. This study aimed to evaluate the prognosis of such patients. Methods Nine patients pathologically diagnosed with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jiayu Yan, Yanlong Duan, Tingting Liu, Jianlin Guo, Chunhui Peng, Wenbo Pang, Dan Zhang, Yun Peng, Yajun Chen
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/e35c896f62e74832b380b08664036347
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e35c896f62e74832b380b08664036347
record_format dspace
spelling oai:doaj.org-article:e35c896f62e74832b380b086640363472021-12-05T12:21:09ZClinical features and outcomes of bowel perforation in primary pediatric gastrointestinal lymphoma10.1186/s12887-021-02944-11471-2431https://doaj.org/article/e35c896f62e74832b380b086640363472021-12-01T00:00:00Zhttps://doi.org/10.1186/s12887-021-02944-1https://doaj.org/toc/1471-2431Abstract Background Whether surgery can improve the prognosis of patients with primary pediatric gastrointestinal lymphoma (PPGL) who experienced bowel perforation remains controversial. This study aimed to evaluate the prognosis of such patients. Methods Nine patients pathologically diagnosed with PPGL who experienced perforation at our center between January 2010 and December 2020 were enrolled and divided into two groups: those with perforation during (n = 4) and before (n = 5) chemotherapy. Their medical records were reviewed, and long-term follow-up was conducted by telephone in February 2021. Results All patients with perforation during chemotherapy were diagnosed with PPGL in the outpatient department. The mean time from outpatient visit to chemotherapy was 17.3 ± 6.1 days. Two patients experienced perforation during the first chemotherapy regimen and received conservative treatment, while the others developed perforation after multiple chemotherapy regimens and underwent surgery. All of the patients received regular chemotherapy and survived for a mean follow-up time of 3.8 ± 1.9 years. No patient with perforation before chemotherapy had a definite diagnosis in the outpatient department. Among these patients, 4 experienced perforation and underwent surgery, of whom 3 developed perforation-related complications and died; the other recurred after chemotherapy. Only the patient who received conservative treatment was diagnosed with PPGL before chemotherapy, received regular chemotherapy, and survived without a recurrence for 1.0 year. Conclusion Prompt diagnosis and chemotherapy improve the prognosis of PPGL. Surgery does not affect the prognosis of patients with perforation during chemotherapy but may accelerate disease progression in patients with perforation before chemotherapy.Jiayu YanYanlong DuanTingting LiuJianlin GuoChunhui PengWenbo PangDan ZhangYun PengYajun ChenBMCarticlePrimary gastrointestinal lymphomaChildrenBowel perforationSurgeryOutcomePediatricsRJ1-570ENBMC Pediatrics, Vol 21, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Primary gastrointestinal lymphoma
Children
Bowel perforation
Surgery
Outcome
Pediatrics
RJ1-570
spellingShingle Primary gastrointestinal lymphoma
Children
Bowel perforation
Surgery
Outcome
Pediatrics
RJ1-570
Jiayu Yan
Yanlong Duan
Tingting Liu
Jianlin Guo
Chunhui Peng
Wenbo Pang
Dan Zhang
Yun Peng
Yajun Chen
Clinical features and outcomes of bowel perforation in primary pediatric gastrointestinal lymphoma
description Abstract Background Whether surgery can improve the prognosis of patients with primary pediatric gastrointestinal lymphoma (PPGL) who experienced bowel perforation remains controversial. This study aimed to evaluate the prognosis of such patients. Methods Nine patients pathologically diagnosed with PPGL who experienced perforation at our center between January 2010 and December 2020 were enrolled and divided into two groups: those with perforation during (n = 4) and before (n = 5) chemotherapy. Their medical records were reviewed, and long-term follow-up was conducted by telephone in February 2021. Results All patients with perforation during chemotherapy were diagnosed with PPGL in the outpatient department. The mean time from outpatient visit to chemotherapy was 17.3 ± 6.1 days. Two patients experienced perforation during the first chemotherapy regimen and received conservative treatment, while the others developed perforation after multiple chemotherapy regimens and underwent surgery. All of the patients received regular chemotherapy and survived for a mean follow-up time of 3.8 ± 1.9 years. No patient with perforation before chemotherapy had a definite diagnosis in the outpatient department. Among these patients, 4 experienced perforation and underwent surgery, of whom 3 developed perforation-related complications and died; the other recurred after chemotherapy. Only the patient who received conservative treatment was diagnosed with PPGL before chemotherapy, received regular chemotherapy, and survived without a recurrence for 1.0 year. Conclusion Prompt diagnosis and chemotherapy improve the prognosis of PPGL. Surgery does not affect the prognosis of patients with perforation during chemotherapy but may accelerate disease progression in patients with perforation before chemotherapy.
format article
author Jiayu Yan
Yanlong Duan
Tingting Liu
Jianlin Guo
Chunhui Peng
Wenbo Pang
Dan Zhang
Yun Peng
Yajun Chen
author_facet Jiayu Yan
Yanlong Duan
Tingting Liu
Jianlin Guo
Chunhui Peng
Wenbo Pang
Dan Zhang
Yun Peng
Yajun Chen
author_sort Jiayu Yan
title Clinical features and outcomes of bowel perforation in primary pediatric gastrointestinal lymphoma
title_short Clinical features and outcomes of bowel perforation in primary pediatric gastrointestinal lymphoma
title_full Clinical features and outcomes of bowel perforation in primary pediatric gastrointestinal lymphoma
title_fullStr Clinical features and outcomes of bowel perforation in primary pediatric gastrointestinal lymphoma
title_full_unstemmed Clinical features and outcomes of bowel perforation in primary pediatric gastrointestinal lymphoma
title_sort clinical features and outcomes of bowel perforation in primary pediatric gastrointestinal lymphoma
publisher BMC
publishDate 2021
url https://doaj.org/article/e35c896f62e74832b380b08664036347
work_keys_str_mv AT jiayuyan clinicalfeaturesandoutcomesofbowelperforationinprimarypediatricgastrointestinallymphoma
AT yanlongduan clinicalfeaturesandoutcomesofbowelperforationinprimarypediatricgastrointestinallymphoma
AT tingtingliu clinicalfeaturesandoutcomesofbowelperforationinprimarypediatricgastrointestinallymphoma
AT jianlinguo clinicalfeaturesandoutcomesofbowelperforationinprimarypediatricgastrointestinallymphoma
AT chunhuipeng clinicalfeaturesandoutcomesofbowelperforationinprimarypediatricgastrointestinallymphoma
AT wenbopang clinicalfeaturesandoutcomesofbowelperforationinprimarypediatricgastrointestinallymphoma
AT danzhang clinicalfeaturesandoutcomesofbowelperforationinprimarypediatricgastrointestinallymphoma
AT yunpeng clinicalfeaturesandoutcomesofbowelperforationinprimarypediatricgastrointestinallymphoma
AT yajunchen clinicalfeaturesandoutcomesofbowelperforationinprimarypediatricgastrointestinallymphoma
_version_ 1718372047830122496